{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:15:39Z","timestamp":1792192539740,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Existing research hints that people living with and beyond cancer are at an increased risk of stroke. However, there is insufficient evidence to appropriately inform guidelines for specific stroke prevention or management for cancer patients. We conducted a systematic review and meta-analysis to describe and quantify stroke incidence in people living with and beyond cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Medline, CINAHL, and EMBASE were searched for epidemiological studies comparing stroke incidence between cancer and non-cancer patients. Reviewers independently extracted data; random-effects meta-analyses and quality assessment were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-six studies were narratively synthesised. Meta-analysis was conducted using seven studies. Methodological quality was high for most studies. Study populations were heterogeneous, and the length of follow-up and risk factors varied. There was a variation in risk between different cancer types and according to stroke type: pancreatic (HR 2.85 (95%\u00a0CI 2.43\u20133.36), ischaemic) (HR 2.28 (95% CI 1.43\u20133.63), haemorrhagic); lung (HR 2.33 (95% CI 1.63\u20133.35), ischaemic) (HR 2.14 (95% CI 1.45\u20133.15), haemorrhagic); and head and neck (HR 1.54 (95%\u00a0CI 1.40\u20131.69), haemorrhagic) cancers were associated with significantly increased incidence of stroke. Risk is  highest within the first 6\u00a0months of diagnosis. Narrative synthesis indicated that several studies also showed significantly increased incidence of stroke in individuals with colorectal cancer, breast cancer, ovarian cancer, nasopharyngeal cancer, leukaemia, and myeloma, and those who have received radiotherapy for head and neck cancers and platinum-based chemotherapy may also have higher stroke incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Stroke incidence is significantly increased after diagnosis of certain cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Implications for Cancer Survivors<\/jats:title>\n                <jats:p>Cardiovascular risk should be assessed during cancer survivorship care, with attention to modifying shared cancer\/cardiovascular risk factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11764-021-01122-7","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T12:02:32Z","timestamp":1636113752000},"page":"1414-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Melanie","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Murchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Derby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel Yuhan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Walji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McLernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Joan","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"1122_CR1","unstructured":"Cancer Research UK. Cancer statistics for the UK. 2019. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics-for-the-uk. Accessed 20 Aug 2020."},{"key":"1122_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2012.366","volume":"107","author":"J Maddams","year":"2012","unstructured":"Maddams J, Utley M, M\u00f8ller H. Projections of cancer prevalence in the United Kingdom, 2010\u20132040. Br J Cancer. 2012;107:1195\u2013202.","journal-title":"Br J Cancer"},{"key":"1122_CR3","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1002\/cam4.1754","volume":"7","author":"D Schoormans","year":"2018","unstructured":"Schoormans D, Vissers PAJ, van Herk-Sukel MPP, Denollet J, Pedersen SS, Dalton SO, et al. Incidence of cardiovascular disease up to 13 years after cancer diagnosis: a matched cohort study among 32757 cancer survivors. Cancer Med. 2018;7:4952\u201363.","journal-title":"Cancer Med"},{"key":"1122_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","volume":"77","author":"BB Navi","year":"2015","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MSV, Panageas KS, et al. Association between incident cancer and subsequent stroke. Ann Neurol. 2015;77:291\u2013300.","journal-title":"Ann Neurol"},{"key":"1122_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jacc.2017.06.047","volume":"70","author":"BB Navi","year":"2017","unstructured":"Navi BB, Reiner AS, Kamel H. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70:92\u2013938.","journal-title":"J Am Coll Cardiol"},{"key":"1122_CR6","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.ejca.2012.01.005","volume":"48","author":"B Zoller","year":"2012","unstructured":"Zoller B, Ji J, Sundquist J, Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48:1875\u201383.","journal-title":"Eur J Cancer"},{"key":"1122_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejca.2011.09.015","volume":"48","author":"B Zoller","year":"2012","unstructured":"Zoller B, Ji J, Sundquist J, Sundquist K. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48:121\u20138.","journal-title":"Eur J Cancer"},{"key":"1122_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00415-015-7954-6","volume":"263","author":"M Kneihsl","year":"2016","unstructured":"Kneihsl M, Enzinger C, W\u00fcnsch G, Khalil M, Culea V, Urbanic-Purkart T, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263:150\u20136.","journal-title":"J Neurol"},{"key":"1122_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-012-1011-4","volume":"111","author":"J-M Kim","year":"2013","unstructured":"Kim J-M, Jung K-H, Park KH, Lee S-T, Chu K, Roh J-K. Clinical manifestation of cancer-related stroke: retrospective case-control study. J Neurooncol. 2013;111:295\u2013301.","journal-title":"J Neurooncol"},{"key":"1122_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.021","volume":"26","author":"S Cutting","year":"2017","unstructured":"Cutting S, Wettengel M, Conners JJ, Ouyang B, Busl K. Three-month outcomes are poor in stroke patients with cancer despite acute stroke treatment. J Stroke Cerebrovasc Dis. 2017;26:809\u201315.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1122_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13120-6","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG, Zhang Y, Tchelebi LT, Mackley HB, Chinchilli VM, Zacharia BE. Stroke among cancer patients. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-13120-6.","journal-title":"Nat Commun"},{"key":"1122_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejca.2004.11.013","volume":"41","author":"G Nilsson","year":"2005","unstructured":"Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Increased incidence of stroke in women with breast cancer. Eur J Cancer. 2005;41:423\u20139.","journal-title":"Eur J Cancer"},{"key":"1122_CR13","first-page":"1039","volume":"2","author":"JL Dearborn","year":"2014","unstructured":"Dearborn JL, Urrutia VC, Zeiler SR. Stroke and cancer \u2013 a complicated relationship. J Neurol Transl Neurosci. 2014;2:1039.","journal-title":"J Neurol Transl Neurosci"},{"key":"1122_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network metaanalyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777\u201384. https:\/\/doi.org\/10.7326\/M14-2385.","journal-title":"Ann Intern Med"},{"key":"1122_CR15","unstructured":"Institute OHR. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed date 13 Mar 2020."},{"key":"1122_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/jth.14475","volume":"17","author":"K Adelborg","year":"2019","unstructured":"Adelborg K, Corraini P, Darvalics B, Frederiksen H, Ording A, Horv\u00e1th-Puh\u00f3 E, et al. Risk of thromboembolic and bleeding outcomes following hematological cancers: a Danish population-based cohort study. J Thromb Haemost. 2019;17:1305\u201318.","journal-title":"J Thromb Haemost"},{"key":"1122_CR17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","volume":"34","author":"SH Armenian","year":"2016","unstructured":"Armenian SH, Xu L, Ky B, Sun C, Farol LET, Pal SK, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34:1122\u201330.","journal-title":"J Clin Oncol"},{"key":"1122_CR18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/STROKEAHA.118.021373","volume":"49","author":"KK Andersen","year":"2018","unstructured":"Andersen KK, Olsen TS. Risk of ischemic and hemorrhagic strokes in occult and manifest cancers. Stroke. 2018;49:1585\u201392.","journal-title":"Stroke"},{"key":"1122_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00404-013-2827-7","volume":"288","author":"W-C Chang","year":"2013","unstructured":"Chang W-C, Muo C-H, Chang S-N, Sung F-C, Chang Y-J, Kao C-H. A nationwide population-based retrospective cohort study: decreased risk of stroke in cervical cancer patients after receiving treatment. Arch Gynecol Obstet. 2013;288:867\u201371.","journal-title":"Arch Gynecol Obstet"},{"key":"1122_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MD.0000000000010133","volume":"97","author":"P-C Chan","year":"2018","unstructured":"Chan P-C, Chang W-L, Hsu M-H, Yeh C-H, Muo C-H, Chang K-S, et al. Higher stroke incidence in the patients with pancreatic cancer. A nation-based cohort study in Taiwan. Medicine. 2018;97:11.","journal-title":"Medicine"},{"key":"1122_CR21","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1161\/STROKEAHA.111.615534","volume":"42","author":"P-C Chen","year":"2011","unstructured":"Chen P-C, Muo C-H, Lee Y-T, Yu Y-H, Sung F-C. Lung cancer and incidence of stroke. A population-based cohort study. Stroke. 2011;42:3034\u20139.","journal-title":"Stroke"},{"key":"1122_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ygyno.2013.02.014","volume":"129","author":"VM Chia","year":"2013","unstructured":"Chia VM, O\u2019Malley CD, Danes MD, Lindquist KJ, Gleeson ML, Kelsh MA, et al. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol. 2013;129:346\u201352.","journal-title":"Gynecol Oncol"},{"key":"1122_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/bjc.2011.361","volume":"105","author":"C-N Chu","year":"2011","unstructured":"Chu C-N, Chen S-W, Bai L-Y, Mou C-H, Hsu CY, Sung F-C. Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study. Br J of Cancer. 2011;105:1419\u201323.","journal-title":"Br J of Cancer"},{"key":"1122_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/coa.12064","volume":"38","author":"C-N Chu","year":"2013","unstructured":"Chu C-N, Chen P-C, Bai L-Y, Muo C-H, Sung F-C, Chen S-W. Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke: a national database, controlled cohort study. Clin Otolaryngol. 2013;38:39\u201347.","journal-title":"Clin Otolaryngol"},{"key":"1122_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/jnci\/djp147","volume":"101","author":"ML De Bruin","year":"2009","unstructured":"De Bruin ML, Dorresteijn LDA, van\u2019t Veer MB, Krol ADG, van der Pal HJ, Kappelle AC, et al. Increased risk of stroke and transient ischaemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101:928\u201337.","journal-title":"J Natl Cancer Inst"},{"key":"1122_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1200\/JCO.2002.20.1.282","volume":"20","author":"LDA Dorresteijn","year":"2002","unstructured":"Dorresteijn LDA, Kappelle AC, Boogerd W, Klokman WJ, Balm AJM, Keus RB, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20:282\u20138.","journal-title":"J Clin Oncol"},{"key":"1122_CR27","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1097\/00005537-200210000-00034","volume":"122","author":"JC Haynes","year":"2002","unstructured":"Haynes JC, Machtay M, Weber RS, Weinstein GS, Chalian AA, Rosenthal DI. Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope. 2002;122:1883\u20137.","journal-title":"Laryngoscope"},{"key":"1122_CR28","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1200\/JCO.2006.06.5516","volume":"24","author":"MJ Hooning","year":"2006","unstructured":"Hooning MJ, Dorresteijn LDA, Aleman BMP, Kappelle AC, Klijn JGM, Boogerd W, et al. Decreased risk of stroke among 10-year survivors of breast cancer. J Clin Oncol. 2006;24:5388\u201394.","journal-title":"J Clin Oncol"},{"key":"1122_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1741-7015-12-53","volume":"12","author":"A-S Kuan","year":"2014","unstructured":"Kuan A-S, Teng C-J, Wu H-H, Su VY-F, Chen Y-T, Chien S-H, et al. Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study. BMC Med. 2014;12:53.","journal-title":"BMC Med"},{"key":"1122_CR30","doi-asserted-by":"publisher","first-page":"e1336","DOI":"10.1097\/MD.0000000000001336","volume":"94","author":"A-S Kuan","year":"2015","unstructured":"Kuan A-S, Chen S-C, Yeh C-M, Hung M-H, Hung Y-P, Chen T-J, et al. Risk of ischemic stroke in patients with gastric cancer. A nationwide population-based cohort study. Medicine. 2015;94:e1336.","journal-title":"Medicine"},{"key":"1122_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1200\/JCO.19.01180","volume":"38","author":"J Lauritsen","year":"2019","unstructured":"Lauritsen J, Hansen MK, Bandak M, Kreiberg MB, Sk\u00f8tt JW, Wagner T, et al. Cardiovascular risk factors and disease after male germ cell cancer. J Clin Oncol. 2019;38:584\u201392.","journal-title":"J Clin Oncol"},{"key":"1122_CR32","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1016\/j.ijrobp.2010.11.036","volume":"81","author":"C-C Lee","year":"2011","unstructured":"Lee C-C, Su Y-C, Ho H-C, Hung S-K, Lee M-S, Chiou W-Y, et al. Increased risk of ischemic stroke in young nasopharyngeal carcinoma patients. Int J Radiation Oncology Biol Phys. 2011;81:e833\u20138.","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"1122_CR33","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.ijrobp.2009.09.061","volume":"78","author":"JH Maduro","year":"2010","unstructured":"Maduro JH, Den Dekker HA, Pras E, De Vries EG, Van der Zee AG, Klokman WJ, et al. Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer. Int J Radiation Oncology Biol Phys. 2010;78:1337\u201344.","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"1122_CR34","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","volume":"130","author":"C Melloni","year":"2017","unstructured":"Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, et al. Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE Trials. Am J Med. 2017;130:1440\u20138.","journal-title":"Am J Med"},{"key":"1122_CR35","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","volume":"107","author":"EC Moser","year":"2006","unstructured":"Moser EC, Noordijk EM, van Leeuwen FE, le Cessie S, Baars JW, Thomas J, et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood. 2006;107:2912\u20139.","journal-title":"Blood"},{"key":"1122_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41416-019-0468-8","volume":"120","author":"IR Moutsten","year":"2019","unstructured":"Moutsten IR, Larsen SB, Dunn-Henriksen AK, Tj\u00f8nneland A, Kjaer SK, Brasso K, et al. Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men. Br J of Cancer. 2019;120:1067\u201374.","journal-title":"Br J of Cancer"},{"key":"1122_CR37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ijc.26022","volume":"130","author":"D Robinson","year":"2012","unstructured":"Robinson D, Garmo H, Lindahl B, Van Hemelrijck M, Adolfsson J, Bratt O, et al. Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. Int J Cancer. 2012;130:478\u201387.","journal-title":"Int J Cancer"},{"key":"1122_CR38","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1245\/s10434-018-6635-y","volume":"25","author":"DW Shin","year":"2018","unstructured":"Shin DW, Suh B, Park Y, Lim H, Suh Y-S, Yun JM, et al. Risk of coronary heart disease and ischemic stroke incidence in gastric cancer survivors: a nationwide study in Korea. Ann Surg Oncol. 2018;25:3248\u201356.","journal-title":"Ann Surg Oncol"},{"key":"1122_CR39","doi-asserted-by":"publisher","first-page":"10313","DOI":"10.1038\/s41598-020-67029-y","volume":"10","author":"DW Shin","year":"2020","unstructured":"Shin DW, Han K, Park HS, Lee S-P, Park SH, Park J. Risk of ischemic heart disease and stroke in prostate cancer survivors: a nationwide study in South Korea. Nat Sci Rep. 2020;10:10313. https:\/\/doi.org\/10.1038\/s41598-020-67029-y.","journal-title":"Nat Sci Rep"},{"key":"1122_CR40","first-page":"1342","volume":"110","author":"S Soisoon","year":"2018","unstructured":"Soisoon S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, et al. Long-term cardiovascular outcomes among endometrial cancer survivors in a large population-based cohort study. J Natl Cancer Inst. 2018;110:1342\u201351.","journal-title":"J Natl Cancer Inst"},{"key":"1122_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","volume":"394","author":"H Strongman","year":"2019","unstructured":"Strongman H, Gadd S, Matthews A, Mansfiled KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019;394:1041\u201354.","journal-title":"Lancet"},{"key":"1122_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-18-0551","volume":"180","author":"B Suh","year":"2019","unstructured":"Suh B, Shin DW, Park Y, Lim H, Yun JM, Song SO, et al. Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea. Eur J Endocrinol. 2019;180:11\u201320.","journal-title":"Eur J Endocrinol"},{"key":"1122_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-8-41","volume":"8","author":"S-J Tsai","year":"2013","unstructured":"Tsai S-J, Hunang Y-S, Tung C-H, Lee C-C, Lee M-S, Chiou W-Y, et al. Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study. Radiat Oncol. 2013;8:41.","journal-title":"Radiat Oncol"},{"key":"1122_CR44","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1200\/JCO.2010.29.1567","volume":"28","author":"M Van Hemelrijck","year":"2010","unstructured":"Van Hemelrijck M, Garmo H, Holmberg L, Ingelsson E, Bratt O, Bill-Axelson A, et al. Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the population-based PCBaSe Sweden. J Clin Oncol. 2010;28:3448\u201356.","journal-title":"J Clin Oncol"},{"key":"1122_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1160\/TH10-12-0778","volume":"106","author":"MPP Van Herk-Sukel","year":"2011","unstructured":"Van Herk-Sukel MPP, Shantakumar S, Kamphuisen PW, Penning-van Beest FJA, Herings RMC. Myocardial infarction, ischaemic stroke, and pulmonary embolism before and after breast cancer hospitalisation. Thromb Haemost. 2011;106:149\u201355.","journal-title":"Thromb Haemost"},{"key":"1122_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00408-013-9485-1","volume":"191","author":"MPP Van Herk-Sukel","year":"2013","unstructured":"Van Herk-Sukel MPP, Shantakumar S, Penning-van Beest FJA, Kamphuisen PW, Majoor CJ, Overbeek LIH, et al. Pulmonary embolism, myocardial infarction and ischemic stroke in lung cancer patients: results from a longituidinal study. Lung. 2013;191:501\u20139.","journal-title":"Lung"},{"key":"1122_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fneur.2019.00579","volume":"10","author":"Y-C Wei","year":"2019","unstructured":"Wei Y-C, Chen K-F, Wu C-L, Lee T-W, Liu C-H, Shyu Y-C, et al. Stroke rate increases around the time of cancer diagnosis. Front Neurol. 2019;10:579.","journal-title":"Front Neurol"},{"key":"1122_CR48","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3109\/00207454.2014.967351","volume":"125","author":"Y-T Wu","year":"2015","unstructured":"Wu Y-T, Chen C-Y, Lai W-T, Kuo C-C, Hunag Y-B. Increasing risks of ischemic stroke in oral cancer patients treated with radiotherapy or chemotherapy: a nationwide cohort study. Int J Neurosci. 2015;125:808\u201316.","journal-title":"Int J Neurosci"},{"key":"1122_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12885-016-2221-5","volume":"16","author":"F Meng","year":"2016","unstructured":"Meng F, Zhu S, Zhao J, Vados L, Wang L, Zhao Y, et al. Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review. BMC Cancer. 2016;16:180.","journal-title":"BMC Cancer"},{"key":"1122_CR50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000503906","volume":"104","author":"R Liu","year":"2020","unstructured":"Liu R, Zhou J, Xia S, Li T. Androgen deprivation therapy and the risk of stroke in patients with prostate cancer: an updated systematic review and meta-analysis. Urol Int. 2020;104:214\u201321.","journal-title":"Urol Int"},{"key":"1122_CR51","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1212\/01.WNL.0000140491.54664.50","volume":"63","author":"CD Bushnell","year":"2004","unstructured":"Bushnell CD, Goldstein LB. Risk of ischemic stroke with tamoxifen treatment with breast cancer: a meta-analysis. Neurology. 2004;63:1230\u20133.","journal-title":"Neurology"},{"key":"1122_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fneur.2019.00233","volume":"10","author":"R Huang","year":"2019","unstructured":"Huang R, Zhou Y, Hu S, Ren G, Cui F, Zhou P-K. Radiotherapy exposure in cancer patients and subsequent risk of stroke: a systematic review and meta-analysis. Front Neurol. 2019;10:233.","journal-title":"Front Neurol"},{"key":"1122_CR53","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25227","volume":"83","author":"BB Navi","year":"2018","unstructured":"Navi BB, Iadecola C. Ischemic stroke in cancer patients: a review of an underappreciated pathology. Ann Neurol. 2018;83:873\u201383.","journal-title":"Ann Neurol"},{"key":"1122_CR54","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1212\/WNL.0000000000011264","volume":"96","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang K, Du P, Yang W, He Y, Li T, et al. Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies. Neurology. 2021;96:e513\u201326.","journal-title":"Neurology"},{"key":"1122_CR55","unstructured":"http:\/\/www.ncin.org.uk\/publications\/survival_by_stage. Accessed 8 Mar 2021."},{"key":"1122_CR56","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/STROKEAHA.109.571356","volume":"41","author":"SG Kim","year":"2010","unstructured":"Kim SG, Hong JM, Kim HY, Lee J, Chung P-W, Park K-Y, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicentre study in Korea. Stroke. 2010;41:798\u2013801.","journal-title":"Stroke"},{"key":"1122_CR57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.clineuro.2005.03.008","volume":"108","author":"SH Li","year":"2006","unstructured":"Li SH, Chen WH, Tang Y, Rau K-M, Chen Y-Y, Huang T-L, et al. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg. 2006;108:150\u20136.","journal-title":"Clin Neurol Neurosurg"},{"key":"1122_CR58","doi-asserted-by":"publisher","first-page":"e102484","DOI":"10.1371\/journal.pone.0102484","volume":"9","author":"P-Y Zuo","year":"2014","unstructured":"Zuo P-Y, Chen X-L, Liu Y-W, Xiao C-L, Liu C-Y. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. PLoS ONE. 2014;9:e102484.","journal-title":"PLoS ONE"},{"key":"1122_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/02841860903524396","volume":"49","author":"V Ranpura","year":"2010","unstructured":"Ranpura V, Hapani S, Chuang J, Wu S. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials. Acta Oncol. 2010;49:287\u201397.","journal-title":"Acta Oncol"},{"key":"1122_CR60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MBC.0000000000000546","volume":"28","author":"Z Lysov","year":"2017","unstructured":"Lysov Z, Dwivedi DJ, Gould TJ, Liaw PC. Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA. Blood Coagul Fibrinolysis. 2017;28:72\u201382.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1122_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijrobp.2016.10.015","volume":"97","author":"C El-Fayech","year":"2017","unstructured":"El-Fayech C, Haddy N, Allodji RS, Veres C, Diop F, Kahlouche A, et al. Cerebrovascular diseases in childhood cancer survivors: role of the radiation dose to Willis circle arteries. Int J Radiat Oncol Biol Phys. 2017;97:278\u201386.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1122_CR62","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1161\/STROKEAHA.111.615203","volume":"42","author":"C Plummer","year":"2011","unstructured":"Plummer C, Henderson RD, O\u2019Sullivan JD, Read SJ. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. Stroke. 2011;42:2410\u20138.","journal-title":"Stroke"},{"key":"1122_CR63","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1161\/STROKEAHA.112.661561","volume":"43","author":"CJ Campen","year":"2012","unstructured":"Campen CJ, Kranick SM, Kasner SE, Kessler SK, Zimmerman RA, Lustig R, et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke. 2012;43:3035\u201340.","journal-title":"Stroke"},{"key":"1122_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1586\/ern.12.20","volume":"12","author":"WA Rocca","year":"2012","unstructured":"Rocca WA, Shuster LT, Brown RD. Could estrogen protect younger menopausal women from stroke? Expert Rev Neurother. 2012;12:363\u20135.","journal-title":"Expert Rev Neurother"},{"key":"1122_CR65","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s13105-012-0159-x","volume":"68","author":"S Petrovska","year":"2012","unstructured":"Petrovska S, Dejnaova B, Jurisic V. Estrogens: mechanisms of neuroprotective effects. J Physiol Biochem. 2012;68:455\u201360.","journal-title":"J Physiol Biochem"},{"key":"1122_CR66","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ygyno.2009.01.021","volume":"113","author":"G Jacobson","year":"2009","unstructured":"Jacobson G, Lammli J, Zamba G, Hua L, Goodheart MJ. Thromboembolic events in patients with cervical carcinoma: incidence and effect on survival. Gynecol Oncol. 2009;113:240\u20134.","journal-title":"Gynecol Oncol"},{"key":"1122_CR67","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/1097-0142(197801)41:1<130::AID-CNCR2820410121>3.0.CO;2-X","volume":"41","author":"GD Silverberg","year":"1978","unstructured":"Silverberg GD, Britt RH, Goffinet DR. Radiation-induced carotid artery disease. Cancer. 1978;41:130\u20137.","journal-title":"Cancer"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-021-01122-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T19:05:34Z","timestamp":1667415934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-021-01122-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s11764-021-01122-7","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All analyses were based on previously published studies; therefore, no ethical approval or patient consent is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}